Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in Chronic Stable Angina Patients with Type 2 Diabetes (TERISA)
NCT01425359Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Sep 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 4 trial of ranolazine in angina pectoris, sponsored by Gilead Sciences. Started Sep 2011; status: completed.
02
Drugs
ranolazine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT01425359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01425359.